Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
By subcutaneous injection (Wegovy): initially 0.25 mg once a week and increased every 4 weeks until the full dose of 2.4 mg is reached
The same spend paired with structured clinical and lifestyle support that delivers 17% to 20% sustained weight loss, meaningful reductions in metabolic risk and measurable downstream healthcare savings is a fundamentally different calculation
It reflects the reality that pharmacological weight loss is a gradual process that plays out over months, not weeks
V., Olson, T
Wegovy is approved for use in people with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related medical condition
US$ 20.20
US$ 26.41
US$ 23.66
US$ 27.01
